Biologicals

Cell Line Development & Engineering will bring together the industry's best scientists and engineers with world-renowned academics to collaborate and share unpublished data, case studies and lessons learned on the critical and emerging topics that are driving this industry.

IBC's Next Generation Protein Therapeutics Summit is the only conference on the market which consistently brings together every leading company and academic scientist working in alternative scaffold and next-generation protein therapeutic development.

IBC has taken the lead to bring all the industry experts together to give you the answers you need to move ahead your discovery, design or development program. This is the first program to combine coverage of ADCs and other bioconjugates so you can expand your knowledge base and move your programs efficiently ahead from bench to bedside.

IBC's Antibody Engineering & Therapeutics meeting has earned its reputation by consistently offering the most current academic research findings and most recent industry updates. Our attendees come back year after year for the information they need to find new approaches to developing novel medicines and vaccines and to improve the safety and efficacy of antibody therapeutics now in development.